Andrej Sali
Corporate Officer/Principal presso The University of California, San Francisco
Profilo
Dr. Andrej Sali is Co-Founder at Global Blood Therapeutics, Inc. and a Professor at The University of California, San Francisco.
Dr. Sali was previously employed as an Associate Professor by The Rockefeller University and Founder by Prospect Genomix, Inc.
He received his undergraduate degree from the University of Ljubljana and a doctorate degree from the Birkbeck University of London.
Posizioni attive di Andrej Sali
| Società | Posizione | Inizio |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Precedenti posizioni note di Andrej Sali
| Società | Posizione | Fine |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
| Prospect Genomix, Inc. | Founder | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Founder | - |
Formazione di Andrej Sali
| University of Ljubljana | Undergraduate Degree |
| Birkbeck University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Prospect Genomix, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Andrej Sali
